Electroconvulsive Therapy Improves Clinical Manifestation with Plasma BDNF Levels Unchanged in Treatment-Resistant Depression Patients

Publisher： Karger

E-ISSN： 1423-0224|68|2|110-115

ISSN： 0302-282x

Source： Neuropsychobiology, Vol.68, Iss.2, 2013-07, pp. : 110-115

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Plasma Amyloid-β Levels in Drug-Resistant Bipolar Depressed Patients Receiving Electroconvulsive Therapy

By  

Neuropsychobiology, Vol. 67, Iss. 4, 2013-04 ,pp. : 185-191

Karger

Access to resources Recommend Favorite

Augmentation of Antipsychotics with Electroconvulsive Therapy in Treatment-Resistant Schizophrenia Patients with Dominant Negative Symptoms: A Pilot Study of Effectiveness

By  

Neuropsychobiology, Vol. 70, Iss. 3, 2014-10 ,pp. : 158-164

Karger

Access to resources Recommend Favorite

Serum Cholesterol in Treatment-Resistant Depression

By  

Neuropsychobiology, Vol. 47, Iss. 3, 2003-05 ,pp. : 146-151

Karger

Access to resources Recommend Favorite

Potentiation of Antidepressants with Lithium or Carbamazepine in Treatment-Resistant Depression

By  

Neuropsychobiology, Vol. 40, Iss. 3, 1999-09 ,pp. : 134-139

Karger

Access to resources Recommend Favorite

Influence of BDNF Variants on Diagnosis and Response to Treatment in Patients with Major Depression, Bipolar Disorder and Schizophrenia

By  

Neuropsychobiology, Vol. 65, Iss. 1, 2011-11 ,pp. : 1-11

Karger

Access to resources Recommend Favorite